Trial intelligence / Profile preview

Maternal and fetal/neonatal corticosteroid pharmacokinetics in threatened preterm birth

NL-OMON25709Recruiting

Sponsor
Erasmus MC
Start
Jan 2021
Countries
1
01

Overview

Open-label, single-arm trial of corticosteroids in preterm birth, sponsored by Erasmus MC. Primary endpoint: Maternal blood pharmacokinetics of the standard corticosteroid regimen. Started Jan 2021; status: recruiting.

02

Drugs

corticosteroids
03

Conditions

preterm birth

Beyond the preview

Go deeper on NL-OMON25709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call